Patenting transcription factors for drug discovery and therapeutics

By Manning A.M.   Gonzales R.   Bennett B.L.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 3, 1997-03 ,pp. : 225-231

Informa Healthcare

Access to resources Recommend Favorite

Advances in anti-obesity therapeutics

By Fong Tung M  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 243-250

Informa Healthcare

Access to resources Recommend Favorite

Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk

By Janero David R   Lindsley Loren   Vemuri Venkata Kiran   Makriyannis Alexandros  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 10, 2011-10 ,pp. : 995-1025

Informa Healthcare

Access to resources Recommend Favorite

b3-adrenergic agonists: potential therapeutics for obesity

By Dow R.L.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1811-1826

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA Therapeutics in Neurological Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 38, 2014-11 ,pp. : 6022-6027

Bentham Science Publishers

Access to resources Recommend Favorite